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Abstract
Identification of differentiating muscle cells generally requires fixation, antibodies directed against muscle specific proteins,
and lengthy staining processes or, alternatively, transfection of muscle specific reporter genes driving GFP expression. In this
study, we examined the possibility of using the robust mitochondrial network seen in maturing muscle cells as a marker of
cellular differentiation. The mitochondrial fluorescent tracking dye, MitoTracker, which is a cell-permeable, low toxicity,
fluorescent dye, allowed us to distinguish and track living differentiating muscle cells visually by epi-fluorescence
microscopy. MitoTracker staining provides a robust and simple detection strategy for living differentiating cells in culture
without the need for fixation or biochemical processing.
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Introduction
Much of our extensive knowledge of the molecular and cell
biology of skeletal muscle differentiation is due to the availability of
immortalized cell lines such as the C2 cell line, with its sub-variants
including the C2C12 line. C2 cells were originally established from
adult satellite cells [1,2]. These cells can proliferate with high
mitogenic stimuli and form multi-nucleated myotubes (MTs) readily
upon reduction of mitogens. However, the differentiation process is
not fully synchronized, and due to stochastic reasons, a significant
portion of the population does not form differentiated MTs,
remaining in a quiescent mono-nucleated state [3]. Therefore, the
ability to separate these populations would be a great advantage in
characterizing the molecular events during muscle differentiation.
To identify terminally differentiating muscle cells, detection of
muscle specific proteins by immuno-fluorescence (IF), immuno-
chemistry or introduction of muscle specific gene promoter-reporter
constructs are commonly used. However, fixation of the cells or
transfection methods may limit downstream applications.
Muscle cells have highly specialized features including a robust
mitochondrial network [4]. Here we report a useful method to
identify differentiating muscle cells without disrupting the
differentiation program. Staining mitochondria with a low toxicity
cell permeable fluorescent dye and visualization with fluorescence
microscopy allows detection of differentiating cells. Using this live-
cell imaging modality, we were able to detect differentiating
muscle cells with minimal invasive manipulation.
Results
Live cell mitochondrial staining exhibits high mitochondrial
reactivity in myotubes but not undifferentiated cells
Since differentiated muscle cells contain an extensive mitochon-
drial network to support the energy demands of this tissue [5,6], we
hypothesized that detection of active mitochondria might allow us
to distinguish differentiating muscle cells from non-differentiating
muscle cells. In order to detect living muscle cells visually, we used a
cell-permeable low toxicity fluorescent dye, MitoTracker Red
CMX-Ros (Invitrogen), which stains mitochondria specifically and
responds to changes in mitochondrial membrane potential [7].
Mitochondria in proliferating C2C12 cells in growth medium (GM;
10%FBS supplemented DMEM) were labelled with MitoTracker
Red (50 nM) for 30 min at 37uC. To visualize the cell nuclei, we
used cell-permeable and fluorescent DNA dye, bisBenzimide H
33342 trihydrochloride (1 mM Hoechst 33342; Sigma).
In order to test mitochondrial reactivity in differentiating cells to
the MitoTracker, C2C12 cells were induced to differentiate in
differentiation medium (DM; 2% FBS containing DMEM) for 4
days. Multi-nucleated MTs formed and some mono-nucleated
cells were observed on the plate (data not shown). Double staining
of mitochondria and nuclei was performed and all nuclei were
visualized by Hoechst 33342 staining. In contrast, the mitochon-
dria in the multi-nucleated MTs but not mono-nucleated cells
were highly reactive with MitoTracker Red. As seen in Figure 1
(higher magnification in A (day2 in DM) and lower magnification
in B (day4 in DM)), the nuclei (blue) of the undifferentiated cells
(indicated by white arrow) are not surrounded by a signal from
mitochondria (red). Since the differences in the red fluorescence
signal intensities are large enough, in short exposure times, the
signals from mitochondria in undifferentiated cells were much
lower relative to that of MTs (Figure 1A, 1B). At day 2, some of
the mono-nucleated cells were MitoTracker positive, but they
show the typical morphological change in the differentiating cells,
such as elongation (bright field micrographs, Fig. 1). In these
experiments, however, we noted that addition of the Hoechst
33342 into the cell-culture medium resulted in inhibition of MT
formation in longer treatments (Figure 1C).
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Next, we sought to determine when this mitochondrial reactivity
change occurs during muscle differentiation. We double-stained
nuclei and mitochondria as described above every two days
following a culture media switch to DM and recorded MT
formation by bright field phase-contrast and fluorescence
microscopy. As seen in Figure 2A, as early as day2, even some
of the mono-nucleated cells showed high MitoTracker reactivity
(MitoTracker Positive Cells; MTP), and the population of MTP
increased as MT formation progressing. Most MTPs, but not all,
are multinucleated MTs in later time points. MTPs in early time
points, for example at day2, are often not multi-nucleated.
However, these cells clearly showed signs of early differentiation
such as cell elongation compared to the flat, ‘‘cobble stone’’
morphology of the mono-nucleated cells as seen before (Figure 2A,
day2). We quantified the degree of differentiation by counting the
number of nuclei in multinucleated ($2) cells and total number of
nuclei in the field (n=6). The total number of nuclei did not
change significantly (Figure 2B) indicating the cells were not
proliferating under these conditions. In agreement with morpho-
logical changes seen in the bright field micrographs, the number of
nuclei in multi-nucleated cells and the percentage of nuclei in
multi-nucleated cells over the total number of nuclei increased as
differentiation progressed (Figure 2B and 2C). Here, both values
change in the total number, and the percentage of the MTPs,
Figure 1. Live cell mitochondrial staining exhibits high mitochondrial reactivity in myotubes but not undifferentiated cells. C2C12
cells were seeded on the cell culture dishes. Upon reaching confluence, the cells were transferred to DM to induce MT formation. The DM was
changed every 2 days. MitoTracker and Hoechst were added into the media for fluorescence staining of mitochondria and nuclei. After 30 min of
incubation at 37uC, live-cell images were recorded by bright field or fluorescence microscopy at day2 (A) and day4 (B). The cells were kept for 4days in
DM with/without Hoechst 33342 (1 mM), and then Hoechst was added to stain nuclei (C). Cell morphology was also recorded by bright-field phase-
contrast microscopy. MitoTracker and Hoechst signals are shown in red and blue, respectively (scale bar in A=10 mm, B=100 mm, and C=50 mm).
doi:10.1371/journal.pone.0028628.g001
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MT formation as described above. At the indicated day, the cells were double stained by MitoTracker and Hoechst 33342 as described above. Live-cell
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2C). As mentioned above, some of the MTPs were mono-
nucleated. Therefore, the number of and the percentage of the
MTPs were higher than those of multi-nucleated cells. We further
quantified red fluorescent signal from MitoTracker during the
course of muscle differentiation by a fluorescent plate reader. In
agreement with our microscopy observations, the fluorescent
signal intensity increased as the progression of muscle differenti-
ation (Figure 2D). Therefore, MTP appears highly correlated with
differentiating morphology and is easily quantifiable.
MyHC and MyoG positive cells are also MitoTracker
positive
To confirm that MTP cells were differentiating cells, we
employed a biochemical approach to identify expression of muscle
specific marker proteins. Figure 3A shows a typical expression
pattern of muscle specific proteins by immuno-blotting analysis
and corresponding morphological changes. A well established
differentiation marker, MyoG, was expressed at day1after
induction of differentiation by DM and reached very high levels
at day2 even though most of the cells were still mono-nucleated at
this point. MyHC accumulation started at day2 when the cells
began fusing and forming multi-nucleated MTs. Therefore, MyoG
and MyHC serve as useful early and late markers of differenti-
ation, respectively. To compare MPTs with MyoG or MyHC
positive cells, a triple staining approach was used. First,
mitochondria and nuclei were stained with MitoTracker and
Hoechst 33342 in living culture conditions, and then the cells were
fixed at day4 and analysed for MyoG or MyHC expression by
immune-fluorescences (IF). MyoG nuclear expression (green) was
detected in the cells showing elongated mono- and multi-nucleated
cells, and MTPs were almost completely matched with MyoG
positive cells (representative micrographs are shown in Figure 3B).
In addition, all MyHC positive cells were MTP cells, but we
occasionally found that MTP cells did not express detectable
amount of MyHC by IF (Figure 3B). Since changes in the
MitoTracker reactivity in differentiating cells become distinguish-
able as MyoG was up-regulated, up-regulation of mitochondrial
biogenesis may occur earlier than MyHC accumulation and
concomitant with MyoG induction. To analyse this in detail, we
fixed cells at day1, 2, and 4 and performed triple–staining (MyoG,
mitochondria, and MyHC). The higher magnification micro-
graphs clearly indicate MyoG, MyHC, or MitoTracker positive
cells (Figure 4), and almost all MyoG positive (.95%) and MyHC
positive (.98%) cells were also MTPs throughout the course of the
differentiation (Figure 4 and Table 1). Therefore, although small
numbers of the MTPs were neither MyoG nor MyHC positives,
MitoTracker can be used to detect majority of differentiating cells
in the early and late stages of differentiation.
MyoD-converted myocytes from fibroblasts can be
identified by MitoTracker
Since MyoD expression is sufficient to convert fibroblast into
myocytes [8], the possibility of whether these reprogrammed
myocytes could be identified by MitoTracker staining was tested.
C3H10T1/2 fibroblast cells were forced to differentiate into MTs
by ectopic expression of MyoD. Transfected cells were marked
and differentiation was monitored by EGFP reporter expression
driven by muscle specific creatin kinase (MCK) promoter (pMCK-
EGFP). After 2days in DM, MyoD expressing cells were elongated
and multi-nucleated and became MCK positive (Figure 5A).
MitoTracker reactivity was distinguishably higher in the cells
showing morphological and biochemical changes. In a detailed
analysis, non-transfected cell (EGFP negative cells) did not show
any morphological changes typical of myocytes. More important-
ly, there was no MitoTracker reactivity observed in the absence of
MyoD-conversion (Figure 5B). On the other hand, MyoD
expressing C3H10T1/2 cells marked either by pCMV-EGFP or
pMCK-EGFP, showed multi-nucleated MTs, induced MCK
promoter activity, and became clearly visible MTPs. Therefore,
these results demonstrate that MitoTracker staining is a highly
efficient method to detect differentiating myocytes.
Mitochondrial activity responds to a positive or a
negative regulator of myogenesis
In order to confirm the positive correlation between mitochon-
drial activity and muscle differentiation, known negative and
positive regulator proteins for myogenesis were expressed
ectopically, and their effect on mitochondrial reactivity for
MitoTracker was measured. To minimize the ‘‘cross-talk’’
between green or yellow fluorescence to red fluorescence signal
from cytoplasm (mitochondria), we choose nuclear localized p53
and JDP2. P53 is up-regulated in both aged muscle and muscle
atrophy [9,10], and required for inhibition of myogenesis by
TNFa [11,12]. In addition, p53 was identified recently as a direct
negative regulator for mitochondrial biogenesis by inhibiting a
master regulator, PGC1a [13]. JDP2 was originally identified as a
c-Jun interacting nuclear protein [14] and later characterized as
an enhancer for skeletal myogenesis [15]. To measure mitochon-
drial reactivity with MitoTracker staining in living cells, we
transfected p53-GFP, EYFP-JDP2, or EYFP fused with SV40
nuclear localization signal (EYFP-NLS) construct [16] to prolifer-
ating MBs to mark transfected cells and stain mitochondria by
MitoTracker. As seen in Figure 4, most of the p53-GFP, EYFP-
JDP2, and EYFP-NLS fusion proteins were localized in the
nucleus in transfected C2C12 cells as reported previously
[12,14,16,17]. MitoTracker staining revealed that EYFP-NLS or
EYFP-JDP2 expression had no apparent effect on mitochondria
activity in C2C12 in GM (Figure 6). However, p53-EGFP
expressing cells had reduced mitochondrial reactivity compared
to the untransfected (GFP-negative) cells. It was noted that much
longer exposure was required to detect fluorescent signals from
mitochondria in the MBs. After 2 days in DM, C2C12 cells started
elongating and forming multi-nucleated myotubes, and as seen
above, the cells indicating early differentiation phenotypes
exhibited relatively higher mitochondrial activity (Figure 6B). In
this condition, EYFP-JDP2 but not all EYFP-NLS expressing cells
were elongated and had higher mitochondrial activity compared
to untransfected cells. p53-EGFP expressing cells were not
observed (data not shown). Therefore, p53 expressing MBs did
images were recorded by both bright field phase-contrast and fluorescence microscopy. MitoTracker and Hoechst signals are shown in red and blue
respectively (A) (scale bar=50 mm). Total number of nuclei, number of nuclei in the multi-nucleated ($2) cells, and in MitoTracker positive cells per
each micrograph were counted (n=6). The average of each categories was graphed (mean 6 st.dev) in panel B. (C) The percentage of nuclei in
multinucleated ($2) cells and MitoTracker positive cells over the total number of nuclei per field (n=6) were calculated and graphed in C (mean 6
st.dev) * (P,0.05 from confluent cells). (D) The same numbers of C2C12 cells were seeded on the cell culture dish (94-well plate (Nalge Nunc
International)), and differentiation induced accordingly. Red fluorescent signal was measured by a plate reader, and the average values (n=4) relative
to that of the confluent condition (CONF (0)) were graphed (mean 6 st.dev).
doi:10.1371/journal.pone.0028628.g002
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reactivity to MitoTracker. In contrast, EYFP-JDP2 expressing cells
were prematually went into myogenic program of differentiation
and concomitantly showed higher mitochondrial activity. These
changes are clearly detected in living differentiating cells without
fixation by a mitochondrial fluorescence dye with fluorescent
Figure 3. MyHC and MyoG positive cells are also MitoTracker positive. C2C12 cells were seeded on the cell culture dishes, and at the
indicated day, live-cell morphology was recorded by a bright field phase-contrast microscopy. The cells were harvested and subjected to (A) western
blotting for analysis of expression levels of the indicated proteins. Actin levels show equal total protein loading. (B) The cells kept for the indicated
number of days in the DM were double stained with MitoTracker and Hoechst. Expression of MyoG or MyHC was visualized by immune-fluorescence.
Representative micrographs shown were recorded by both bright field phase-contrast and fluorescence microscopy. MitoTracker, Hoechst, and MyoG
or MyHC signals are shown in red, blue, and green respectively (scale bar in=50 mm).
doi:10.1371/journal.pone.0028628.g003
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assessing myogenesis is reliable and effective.
Discussion
Here, we report a simple, quick and effective method to identify
differentiating muscle cells based on mitochondrial activity with a
cell-permeable fluorescent dye, MitoTracker. Since this method is
quick and robust and involves minimal manipulation, it is highly
applicable for many downstream applications. Since a variety of
cell permeable low-toxic fluorescence DNA dyes are commercially
available, for example we also used Hoechst 33342 and SYBR-
green (data not shown), mitochondrial reactivity to the could be
quantified by a fluorescence detector easily and standardized to
the relatively constant DNA fluorescence signal. Furthermore,
since this double staining method of living cell does not require
lengthy multi-step manipulations, it could easily be applied to a
high throughput format. For example, screening of libraries,
including chemicals, genomic etc, which affect muscle regener-
ation or maintenance using a C2C12 cell model could be
envisioned. Such an approach could potentially be used to
identify drugs which regulate muscle maturation and growth in a
variety of pathological and physiological contexts [18,19,20,21].
In summary we report a highly robust and rapid method to
identify differentiating skeletal muscle cells using a mitochondrial
specific fluorescence dye. Since live cells can be visualized and
would be sorted by differences in the fluorescence signal, this
method provides a substantial advantage compared to other
methods that require cessation of the culture and further
manipulation.
Figure 4. MyHC and MyoG positive cells are also MitoTracker positive. C2C12 cells were seeded on glass-bottom dishes. Upon reaching
confluence, the cells were kept in DM for the indicated number of days to induce MT formation. Cells were subsequently double stained with
MitoTracker and Hoechst as described above. Expression of MyoG or MyHC was visualized by immunofluorescence. Representative micrographs
shown were recorded by fluorescence microscopy. MitoTracker, Hoechst, and MyoG or MyHC signals are shown in red, blue, and green respectively
(scale bar in=10 mm).
doi:10.1371/journal.pone.0028628.g004
Table 1. Quantification of correlation between MyoG or MyHC positive cells and MitoTracker positive cells.
(% of nuclei) day1 day2 day4
MyoG MyoG MyHC MyoG MyHC
MyoG&MitoTracker double positive/MyoG positive 95.5 100.0 N/A 96.5 N/A
MyoG&MitoTracker double positive/MitoTracker positive 85.1 84.2 N/A 84.6 N/A
MyHC&MitoTracker double positive/MyHC positive N/A N/A 98.1 N/A 100.0
MyHC&MitoTracker double positive/MitoTracker positive N/A N/A 86.7 N/A 80.2
Myotubes during differentiation were stained with MitoTracker and Hoechst and MyoG or MyHC. The total numbers of nuclei in MyoG-positive, MyHC-positive, and
MitoTracker-positive cells were counted using each fluorescence micrographs (n=12). The total numbers of nuclei in double (‘‘MyoG and MitoTracker’’ or ‘‘MyHC and
MitoTracker’’) positive cells were also counted using merged micrographs (n=12). The percentage of total number of nuclei in each double positive cell over the total
number of the nuclei in indicated single positive cells was calculated.
doi:10.1371/journal.pone.0028628.t001
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Cell culture
C2C12 myoblasts and C3H10T1/2 fibroblasts were obtained
from American Type Culture Collection (CLR-1772 and CCL-
226) and cultured in growth medium (GM) consisting of 10% fetal
bovine serum (Sigma, F10511) in high-glucose Dulbecco’s
modified Eagle’s medium (Gibco) supplemented with 1%
penicillin-streptomycin (Invitrogen) and MEM non-essential
amino acids (Gibco, 11140) at 37uC and 5% CO2. Myotube
formation was induced by replacing GM with differentiation
medium (DM), which consisted of 2% FBS in Dulbecco’s modified
Eagle’s medium supplemented with 1% penicillin-streptomycin
and MEM non-essential amino acids.
Mitochondria and Nuclei double staining
MitoTrackerHRed CMXRos (Invitrogen, M7512) and Hoechst
33342 (Sigma, B2261) were added into the culture media at final
concentrations of 50 nM and 1 mM respectively. The cells were
incubated under normal culture conditions for 30 min, and then
visualized by fluorescence microscopy (Axiovert 200 M; Carl
Zeiss).
Red fluorescent signal quantification by a plate reader
The same number of cells were plated onto 94-well plate (Nalge
Nunc International; 165305), and 2 days following seeding, the
cells were transferred to DM to induce muscle differentiation. At
the required time points, the cells were stained with MitoTracker
and washed twice with 1XPBS to remove phenol-Red containing
medium. Red fluorescent signals were measured by a plate reader
(Perkin Elmer; EnVision 2104 multilabel Reader).
Immuno-blotting analysis
Total cellular protein extracts were prepared in Nonidet P-40
lysis buffer containing 0.1% Nonidet P-40, 150 mM NaCl, 1 mM
EDTA, 50 mM Tris-HCl pH 8.0, 1 mM sodium vanadate, 1 mM
PMSF, supplemented with a protease inhibitor mixture (Sigma, P-
8340) as described previously [22].
Sarcomeric Myosin Heavy Chain and Myogenin detection
by IF
MitoTracker and Hoechst stained cells were washed with
Phosphate-buffered saline (PBS, pH 7.6) and fixed with 90%
methanol at 220uC for 6 min. After fixation, the cells were
incubated in 5% FBS in PBS for 30 min at 37uC for blocking and
then incubated for 60 min at room temperature with MF-20
(primary antibody for MyHC) or F5D (for MyoG) (DSHB,
University of Iowa) in PBS. After incubation, the cells were washed
three times with PBS and incubated for 60 min at room
temperature with Alexa FlourH 488 goat anti-mouse IgG
secondary antibody (Invitrogen, A11029). The cells were again
washed three times with PBS. Images were recorded with a
microscope (Axiovert 200 M; Carl Zeiss) with Quorum Angstrom
Optigrid system (Quorum).
Figure 5. MyoD-converted myocytes from fibroblasts can be identified by MitoTracker. MyoD expression vector (pMT2-MyoD) or empty
vector (pMT2) with either pCMV-EGFP or pMCK-EGFP was co-transfected into C3H10T1/2 fibroblasts. The cells were allowed an initial 2 days recovery
in GM, followed by DM for 2 days. Nuclei and mitochondria were live-stained with Hoechst and MitoTracker and EGFP signal was recorded by
fluorescence microscopy (scale bar in A=50 mm, B=10 mm).
doi:10.1371/journal.pone.0028628.g005
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The reporter construct pMCK-EGFP was a gift from A. Ferrer-
Martinez (Universitat de Barcelona, Spain). pMT2-MyoD was
provided by S.Tapscott [23]. P53-EGFP mammalian expression
construct was obtained from Addgene (plasmid #11770) and
described elsewhere [16]. EYFP-NLS was constructed of insertions
of an ORF of the PCR amplified EYFP from pEYFP-N1
(Clontech) at Xho I/EcoR I site and a nuclear localization signal
(NLS) sequence of the NLS of the large tumour antigen
(PKKKRKVED; BK polyomavirus) at EcoR I/Hind III sites of
pcDNA3.1(2) (Invitrogen) in the same reading frame. EYFP-JDP2
was constructed of insertions of an open reading frame of the PCR
amplified EYFP from pEYFP-N1 (Clontech) at Hind III/EcoR I
site and JDP2 ORF RT-PCR amplified cDNA from total C2C12
RNA extracted by TRIzol (Invitrogen) according to the manu-
facture’s protocol into pcDNA3 (Invitrogen). All transfections were
performed with lipofectamine 2000 (Invitrogen) according to the
manufacturer’s protocol.
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Figure 6. Mitochondrial activity responds to a positive or a negative regulator of myogenesis. C2C12 cells were transfected with p53-
EGFP, EYFP-JDP2, or EYFP-NLS. Expression of fusion proteins, mitochondria (MitoTracker), and nuclei (Hoechst 33342) were visualized by fluorescence
microscopy as described in Methods section. Micrographs were taken at 24 hrs after transfection (cells were in GM for 24 hars) in A, or 72 hrs after
transfection (cells were kept in 48 hrs in DM) in B. MitoTracker, Hoechst, and transfected fusion proteins signals are shown in red, blue, and green
respectively. White arrow indicates cells expressing an indicated fluorescence fusion protein. Merged image is shown in the middle panel. Intensityo f
MitoTracker signals were measured using ImageJ program (NIH) (top panel) based on the MitoTracker signal (Bottom panel). Micrographs shown are
representative of the samples (n$6) (scale bar=10 mm).
doi:10.1371/journal.pone.0028628.g006
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